Matthew Kaplan - Jun 12, 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Director
Signature
/s/ Matthew Kaplan
Stock symbol
NVCT
Transactions as of
Jun 12, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 04:31 PM
Previous filing
Jun 13, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kaplan Matthew L. Director C/O NUVECTIS PHARMA, INC.,, 1 BRIDGE PLAZA, SUITE 275, FORT LEE /s/ Matthew Kaplan 2025-06-12 0001895952

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +30K +35.82% $0.00 114K Jun 12, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Kaplan's continued service on the Company's Board of Directors on such dates.